Branding and series A launch for a biotechnology company pursuing vision-restoring engineered cell-based therapeutics.
Rebrand to usher in the next phase of the C4 Therapeutics story.
Re-imagined brand identity supports immuno-oncology company’s march to the clinic
A clinical-stage debut for a precision player in the neuro space
New company name and brand identity support a vision fueled by optimism
New brand and website for a pioneering company exploring the vast landscape of the dark genome
Strategic communications springboard into a competitive market
New website signals a novel approach to immunotherapy
